Registry study finds GLP-1s cut BMI 2.3% in young type 2 diabetes patients
Among 240 patients with a median age of 16.4 years, 37% achieved at least a 5% drop in age-adjusted BMI over a median 11 months of treatment.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 2 06:15 ETSource: Drugs.com
The wire
- 01Ulm University researchers analyzed nearly 1,900 people aged 6 to 24 with type 2 diabetes in a German, Austrian and Luxembourg registry from 2019 to 2025; GLP-1 prescribing rose from 6.3% to 27.2%.
- 02In the 240-patient treated subset, mean age-adjusted BMI fell 2.3%, a quarter reached 10% reduction, and hypertension incidence dropped from 60% to 52%.
- 03Findings were presented at the EASD meeting in Milan and are real-world and uncontrolled; US labels cover ages 12 and up, while Europe allows weight-loss use from age 6.
From the source
Read at drugs.comGLP-1s Show Benefit For Kids With Type 2 Diabetes
FRIDAY, Oct 2, 2026 — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and blood sugar control.“Our results confirm that GLP-1 receptor agonists...
